Literature DB >> 30982352

miR-632 Functions as Oncogene in Hepatocellular Carcinoma via Targeting MYCT1.

Jian Pu1, Jianchu Wang1, Zuoming Xu2, Yuan Lu2, Xianjian Wu2, Yi Wu2, Zesheng Shao2, Qianli Tang3, Huamei Wei4.   

Abstract

microRNAs (miRNAs) have been widely recognized as crucial regulators for tumorigenesis. However, the role of miR-632 in hepatocellular carcinoma (HCC) remains largely unknown. miR-632 expression in HCC cell lines was determined by quantitative real-time polymerase chain reaction. The role of miR-632 expression on overall survival of HCC patients was examined on the Kaplan-Meier plotter Web site. The dual luciferase reporter method was performed to investigate whether myc target 1 (MYCT1) was a target of miR-632. Cell counting kit-8 assay, colony formation assay, and Transwell invasion assay were performed to examine cell proliferation, colony formation, and cell invasion of HCC cells. The results showed miR-632 expression was elevated in HCC cell lines compared to normal cell lines. Loss-of-function experiments demonstrated that miR-632 downregulation was able to inhibit HCC cell proliferation, colony formation, and cell invasion. Moreover, miR-632 could negatively regulate the expression of MYCT1 in HCC cells. Importantly, the study showed miR-632 and MYCT1 were negatively correlated by analyzing the public data sets obtained from the Gene Expression Omnibus. Knockdown of MYCT1 by small interfering RNA partially reversed the effects of miR-632 on HCC cell events. The present study suggests that miR-632 regulates growth and invasion of HCC cells through targeting MYCT1.

Entities:  

Keywords:  MYCT1; hepatocellular carcinoma; miR-632; oncogene; prognosis

Mesh:

Substances:

Year:  2019        PMID: 30982352     DOI: 10.1089/humc.2019.040

Source DB:  PubMed          Journal:  Hum Gene Ther Clin Dev        ISSN: 2324-8637            Impact factor:   5.032


  4 in total

1.  LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells.

Authors:  Liankang Sun; Liang Wang; Tianxiang Chen; Yu Shi; Bowen Yao; Zhikui Liu; Yufeng Wang; Qing Li; Runkun Liu; Yongshen Niu; Kangsheng Tu; Qingguang Liu
Journal:  Cell Death Dis       Date:  2020-02-05       Impact factor: 8.469

2.  Establishment and Validation of a Ferroptosis-Related Long Non-Coding RNA Signature for Predicting the Prognosis of Stomach Adenocarcinoma.

Authors:  Shuqiong Zhang; Naisheng Zheng; Xiaocui Chen; Kun Du; Junyao Yang; Lisong Shen
Journal:  Front Genet       Date:  2022-02-15       Impact factor: 4.599

3.  miR-455 Inhibits the Viability and Invasion by Targeting RAB18 in Hepatocellular Carcinoma.

Authors:  Chenghong Wang; Guicai Zhu; Miaolin Yu; Xiufang Mi; Honghua Qu
Journal:  J Oncol       Date:  2021-05-27       Impact factor: 4.375

4.  Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma.

Authors:  He Wang; Huiwen Wang; Wenyu Cui; Qiao Zhang; Jing Li; Qi Zhang
Journal:  Diagn Pathol       Date:  2021-06-11       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.